Healthpeak Properties misses Q2 earnings estimates, lowers guidance; Shares fall

Published 24/07/2025, 21:58
 Healthpeak Properties misses Q2 earnings estimates, lowers guidance; Shares fall

DENVER - Healthpeak Properties, Inc. (NYSE:DOC) reported second-quarter earnings that fell short of analyst expectations, with net income of $0.05 per share missing estimates by $0.01. The healthcare real estate investment trust saw its shares fall 1.4% following the announcement.

Revenue for the quarter came in at $694.35 million, exceeding the consensus estimate of $689.32 million. The company reported FFO as Adjusted of $0.46 per share and Total (EPA:TTEF) Merger-Combined Same-Store Cash (Adjusted) NOI growth of 3.5% YoY. Revenue increased from the same quarter last year when the company reported $695.5 million.

Despite the earnings miss, Healthpeak maintained its full-year 2025 guidance for FFO as Adjusted per share of $1.81-$1.87 and Total Merger-Combined Same-Store Cash NOI growth of 3.0%-4.0%. However, the company lowered its diluted earnings per share guidance to $0.25-$0.31 from the previous range of $0.30-$0.36.

The company reported solid leasing momentum with outpatient medical new and renewal lease executions totaling 1 million square feet, with 85% retention and +6% cash releasing spreads on renewals. Lab new and renewal lease executions totaled 503,000 square feet, with 87% retention and +6% cash releasing spreads.

During the quarter, Healthpeak entered into two new development agreements with a combined projected cost of $148 million to support Northside Hospital’s continued outpatient expansion in the Atlanta market. The company also maintained a strong balance sheet with Net Debt to Adjusted EBITDAre at 5.2x for the quarter.

Healthpeak declared a monthly common stock cash dividend of $0.10167 per share for each month of the third quarter, representing an annualized dividend amount of $1.22 per share.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.